J. Thistlethwaite to Cytomegalovirus Infections
This is a "connection" page, showing publications J. Thistlethwaite has written about Cytomegalovirus Infections.
Connection Strength
0.078
-
Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med. 1995 Jul 01; 123(1):18-26.
Score: 0.029
-
OKT3 induction in pediatric renal transplantation. Pediatr Nephrol. 1993 Feb; 7(1):45-9.
Score: 0.024
-
Seropositivity in liver transplant recipients as a predictor of cytomegalovirus disease. J Infect Dis. 1988 Feb; 157(2):383-5.
Score: 0.017
-
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. Transplantation. 1996 Sep 15; 62(5):594-9.
Score: 0.008